Safety and immunogenicity of Vi-DT conjugate vaccine among 6-23-month-old children: Phase II, randomized, dose-scheduling, observer-blind Study

BACKGROUND: Typhoid causes significant mortality among young children in resource-limited settings. Conjugate typhoid vaccines could significantly reduce typhoid-related child deaths, but only one WHO-prequalified typhoid conjugate vaccine exists for young children. To address this gap, we investiga...

Descripción completa

Detalles Bibliográficos
Autores principales: Capeding, Maria Rosario, Sil, Arijit, Tadesse, Birkneh Tilahun, Saluja, Tarun, Teshome, Samuel, Alberto, Edison, Kim, Deok Ryun, Park, Eun Lyeong, Park, Ju Yeon, Yang, Jae Seung, Chinaworapong, Suchada, Park, Jiwook, Jo, Sue-Kyoung, Chon, Yun, Yang, Seon-Young, Ryu, Ji Hwa, Cheong, Inho, Shim, Kyu-Young, Lee, Yoonyeong, Kim, Hun, Lynch, Julia A., Kim, Jerome H., Excler, Jean-Louis, Wartel, T. Anh, Sahastrabuddhe, Sushant
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7599314/
https://www.ncbi.nlm.nih.gov/pubmed/33150320
http://dx.doi.org/10.1016/j.eclinm.2020.100540

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7599314/
https://www.ncbi.nlm.nih.gov/pubmed/33150320
http://dx.doi.org/10.1016/j.eclinm.2020.100540

Ejemplares similares